Thieme E-Books & E-Journals -
Drug Res (Stuttg) 2022; 72(05): 255-258
DOI: 10.1055/a-1785-3936
Original Article

A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies

Authors

  • Zhanna Buzitskaya

    1   Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII)
  • Kira Stosman

    1   Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII)
  • Berik Khairullin

    2   The Research Institute for Biological Safety Problems, Gvardeisky, Republic of Kazakhstan (RIBSP CS MES RK)
  • Marhabat Kassenov

    2   The Research Institute for Biological Safety Problems, Gvardeisky, Republic of Kazakhstan (RIBSP CS MES RK)
  • Ainur Nurpeisova

    2   The Research Institute for Biological Safety Problems, Gvardeisky, Republic of Kazakhstan (RIBSP CS MES RK)
  • A. Abylai Sansyzbay

    2   The Research Institute for Biological Safety Problems, Gvardeisky, Republic of Kazakhstan (RIBSP CS MES RK)
  • Anna-Polina Shurygina

    1   Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII)
  • Andrey Aleksandrov

    1   Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII)
  • Konstantin Sivak

    1   Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII)
  • Marina Stukova

    1   Smorodintsev Research Institute of Influenza, St. Petersburg, Russian Federation (SRII)